Xie Z, Gu Y, Xie X, Lin X, et al. Lung Adenocarcinoma Harboring Concomitant EGFR Mutations and BRAF V600E Responds to a Combination of Osimertinib and Vemurafenib to Overcome Osimertinib Resistance. Clin Lung Cancer 2021;22:e390-e394.
PMID: 32693944